Effect of enalapril on diabetic rat myocardial ultrastructure.
- Author:
Chun-sheng XU
1
;
Zhi-liang LI
;
Shi-rong XUE
;
Quan-neng YAN
;
Hong-chao WU
Author Information
- Publication Type:Journal Article
- MeSH: Angiotensin-Converting Enzyme Inhibitors; pharmacology; Animals; Diabetes Mellitus, Experimental; drug therapy; pathology; Enalapril; pharmacology; Male; Myocardium; ultrastructure; Rats; Rats, Wistar; Streptozocin
- From: Journal of Southern Medical University 2007;27(11):1726-1727
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the changes in the myocardial ultrastructure of diabetic rats and the effect of enalapril treatment.
METHODSMale Wistar rats were divided into 3 groups, namely the control group, diabetic group and enalapril intervention group. Diabetes was induced with peritoneal injection of streptozotocin in the latter 2 groups, and in enalapril group, the rats were treated with enalapril at the daily oral dose of 2 mg/kg for 1, 3 and 5 months after streptozotocin injection. Histological analysis of the left ventricular tissue was performed with transmission electron microscope 1, 3, and 5 months after establishment of diabetes.
RESULTSOnset of myocardial damages was observed 1 month after the development of diabetes in the rats with gradual time-dependent exacerbation. Enalapril treatment could partially reverse the myocardial destruction in the diabetic rats.
CONCLUSIONEnalapril intervention may improve the ultrastructural pathology of the myocardium in diabetic rats, which is suggestive of the action mechanisms of angiotensin-converting enzyme inhibitors in myocardium preservation.